Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets（Ⅰ）

Approval Number

国药准字H20233988

Company上海迪赛诺医药集团股份有限公司

Registration Date

August 1, 2023

Drug Information

Generic Name

依非米替片(Ⅰ)

Dosage Form

片剂

Strength

每片含依非韦伦0.4g，拉米夫定0.3g，富马酸替诺福韦二吡呋酯0.3g

Drug Type

化学药品

Registration Date

August 1, 2023

Company Information

Applicant Company

Company Name上海迪赛诺医药集团股份有限公司

Company Address

中国（上海）自由贸易试验区张衡路1479号1幢

Manufacturing Company

Company Name上海迪赛诺医药集团股份有限公司

Company Address

中国（上海）自由贸易试验区张衡路1479号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy